Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Glucose 400 mg/g oral gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride+glucose 0.225%/5% infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride+glucose 0.18%/4% infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride+glucose 0.18%/10% infusion (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride 0.45%/glucose 2.5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride 0.45%/glucose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride+glucose 0.9%/5% infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing glucose and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 60g injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 25% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5g/100mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5% injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose preparation |
Is a |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10mmol/dextrose 4%/saline 0.18% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10mmol/dextrose 5%/saline 0.45% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride+dextrose/saline 4%/0.18% 13.5mmol/500mL infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20mmol/dextrose 4%/saline 0.18% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20mmol/dextrose 4%/saline 0.18% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 27mmol/dextrose 4%/saline 0.18% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 40mmol/dextrose 4%/saline 0.18% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 10mmol/glucose 5% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 13.5mmol/glucose 5% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20mmol/glucose 5% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 20mmol/glucose 5% infusion solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 27mmol/glucose 5% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride 40mmol/glucose 5% infusion solution 1L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium+dextrose infusion (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5% in 0.2% Normal Saline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride 0.18%/glucose 5% infusion solution bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5g/100mL (5%) injection solution 1000mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 60% in water intravenous solution 1000mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5g/100mL (5%) injection solution 150mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Infant dextrose 25% injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5g/100mL (5%) injection solution 500mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 60% in water intravenous solution 500mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5g/100mL (5%) injection solution 10mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5g/100mL (5%) injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5g/100mL (5%) injection solution 25mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5g/100mL (5%) injection solution 100mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5g/100mL (5%) injection solution 250mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 5g/100mL (5%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride 0.18%/glucose 4% infusion solution 500 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride 0.18%/glucose 4% infusion solution 1 L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride 0.18%/glucose 4% infusion solution 500 mL polyethylene bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride 0.9%/glucose 5% infusion solution 500 mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride 0.9%/glucose 5% infusion solution 1 L bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium chloride 0.9%/glucose 5% infusion solution 500 mL polyethylene bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 10% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 20% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 30% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 40% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 500 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 60% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose 70% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Alcohol + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Theophylline + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lactated Ringer's solution + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lactated Ringer's solution and 2.5% dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lactated Ringer's solution + 5% dextrose + 0.15% potassium hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Milrinone + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Morphine sulfate + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Penicillin G + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bupivacaine + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cefoxitin + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bupivacaine hydrochloride 7.5mg/dextrose 82.5mg injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium+dextrose/saline infusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Potassium chloride+dextrose/saline 10%/0.45% 10mmol/500mL infusion (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing glucose and potassium chloride and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dextrose + potassium chloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glucose 5% bladder irrigation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing glucose and potassium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Continuous infusion of dextrose saline |
Direct substance |
False |
Dextrose preparation |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |